Intraperitoneal Catumaxomab Therapy in a Cirrhotic Patient with Malignant Ascites due to Urethelial Carcinoma: A Case Report

Publisher： Karger

E-ISSN： 2296-5262|35|10|592-594

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.35, Iss.10, 2012-09, pp. : 592-594

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Malignant Ascites with a Second Cycle of Catumaxomab in Gastric Signet Cell Carcinoma - a Report of 2 Cases

By  

Oncology Research and Treatment, Vol. 37, Iss. 11, 2014-07 ,pp. : 674-677

Karger

Access to resources Recommend Favorite

Weekly Intravenous and Intraperitoneal Paclitaxel Combined with S-1 for Malignant Ascites due to Advanced Gastric Cancer

By  

Oncology, Vol. 78, Iss. 1, 2010-03 ,pp. : 40-46

Karger

Access to resources Recommend Favorite

Intraperitoneal bleomycin for sarcomatosis‐related malignant ascites: Prolonged symptom relief

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 10, 2015-10 ,pp. : 1868-1869

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Pregnant Patient with Adrenocortical Carcinoma: Case Report

By  

Oncology Research and Treatment, Vol. 35, Iss. 9, 2012-08 ,pp. : 517-519

Karger

Access to resources Recommend Favorite

Treatment with Ipilimumab: A Case Report of Complete Response in a Metastatic Malignant Melanoma Patient

By  

Case Reports in Oncology, Vol. 6, Iss. 2, 2013-05 ,pp. : 285-288

Karger

Access to resources Recommend Favorite